Bain Capital

Lincoln Financial Group is a Fortune 500 insurance and financial services company based in Radnor, Pennsylvania, established in 1905 with the endorsement of Robert Todd Lincoln, the son of Abraham Lincoln. The company is dedicated to providing a wide range of products, including life insurance, annuities, retirement plan services, and group protection. It focuses on wealth protection, accumulation, and retirement income solutions, aiming to help individuals secure better futures for themselves and their families. With over a century of experience, Lincoln Financial Group has built its reputation on the principles and ideals associated with Abraham Lincoln, emphasizing honesty and dependability in its financial services.

Century Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies derived from induced pluripotent stem cells (iPSCs) to treat hematologic and solid malignancies. Founded in 2018 and headquartered in Philadelphia, Pennsylvania, the company utilizes a specialized platform that integrates gene editing and protein engineering to create allogeneic therapies. This platform allows for the generation of master cell banks of modified immune effector cells, specifically engineered to optimize performance and reduce the risk of rejection by the host immune system. By employing advanced technologies such as CRISPR-mediated gene editing and proprietary chimeric antigen receptors, Century Therapeutics aims to address significant unmet medical needs in cancer and other diseases.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

Hand In Hand Soap, founded in 2011 by Bill Glaab and Courtney Apple, is a personal care brand based in Wynnewood, Pennsylvania. The company is committed to social responsibility through its Give Back program, which ensures that for every product sold, a bar of soap and access to clean water is donated to a child in need. Over the past decade, Hand In Hand has donated over 13 million bars of soap and provided thousands with clean water access. The brand's product range includes bar soap, liquid hand soap, hand sanitizer, body wash, sugar scrubs, and lotions. Additionally, Hand In Hand emphasizes sustainability by producing only palm oil-free products and raising awareness about the environmental and human rights issues associated with palm oil production.

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for rare seizure disorders and neuropsychiatric conditions. The company's primary product candidate, ganaxolone, is an allosteric modulator of GABAA receptors, designed for both intravenous and oral administration for various patient populations. It aims to address multiple indications, including status epilepticus, cyclin dependent kinase-like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, postpartum depression, and treatment-resistant depression. Marinus Pharmaceuticals collaborates with NovaMedica and has license agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals to advance its research and therapeutic offerings. Founded in 2003, the company is headquartered in Radnor, Pennsylvania.

Idelic is a driver management platform founded in 2016 and based in Pittsburgh, Pennsylvania. It focuses on the transportation industry by consolidating fleet data systems and automating compliance processes to enhance driver safety. The platform integrates data from various technology sources into a unified system, allowing clients to gain predictive insights and effectively manage their safety operations. By leveraging data organization and artificial intelligence, Idelic aims to prevent crashes, reduce driver turnover, and lower insurance costs. The company's innovative approach helps identify at-risk drivers before incidents occur, contributing to a safer and more efficient fleet management experience.

Idelic is a driver management platform founded in 2016 and based in Pittsburgh, Pennsylvania. It focuses on the transportation industry by consolidating fleet data systems and automating compliance processes to enhance driver safety. The platform integrates data from various technology sources into a unified system, allowing clients to gain predictive insights and effectively manage their safety operations. By leveraging data organization and artificial intelligence, Idelic aims to prevent crashes, reduce driver turnover, and lower insurance costs. The company's innovative approach helps identify at-risk drivers before incidents occur, contributing to a safer and more efficient fleet management experience.

Penn Foster College, Penn Foster Career School, and Penn Foster High School are part of Penn Foster, Inc., a global leader in online education. For more than 118 years, Penn Foster has been providing accredited career-focused degree and vocational programs in the fields of allied health, business, technology, education, and select trades. Nationally and regionally accredited Penn Foster High School (www.PennFosterHighSchool.com) and Penn Foster Career School (www.pennfoster.edu) are headquartered in Scranton, PA, with regional offices in Montreal, Canada. Penn Foster College is headquartered in Scottsdale, Arizona.

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for rare seizure disorders and neuropsychiatric conditions. The company's primary product candidate, ganaxolone, is an allosteric modulator of GABAA receptors, designed for both intravenous and oral administration for various patient populations. It aims to address multiple indications, including status epilepticus, cyclin dependent kinase-like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, postpartum depression, and treatment-resistant depression. Marinus Pharmaceuticals collaborates with NovaMedica and has license agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals to advance its research and therapeutic offerings. Founded in 2003, the company is headquartered in Radnor, Pennsylvania.

4moms is a company based in Pittsburgh, Pennsylvania, that specializes in developing robotics technology-based products designed for children from prenatal stages to preschool age. By introducing innovative technology to the juvenile industry, 4moms addresses the practical needs of parents with a range of childcare products. The company offers a variety of items, including baby gear and toys, aimed at fulfilling the diverse requirements of young children. With a team of over forty engineers, designers, and developers, 4moms has successfully placed its products in more than 500 stores across 24 countries, making a significant impact in the $8.9 billion U.S. juvenile products market.

Dynamics Inc. designs and manufactures interactive payment cards that utilize programmable magnetic stripes to enhance electronic payment systems. Founded in 2007 and headquartered in Cheswick, Pennsylvania, the company offers a range of products, including multi-purpose security and loyalty cards for banks, as well as loyalty systems for merchants and health cards for consumers. Dynamics' technology allows for customizable features, providing enhanced choice, control, convenience, and security in transactions. The company has established strategic partnerships with SoftBank Corp. and its subsidiary. Dynamics operates as a subsidiary of Canadian Imperial Bank of Commerce, focusing on transforming payment methods through innovative card solutions.

4moms is a company based in Pittsburgh, Pennsylvania, that specializes in developing robotics technology-based products designed for children from prenatal stages to preschool age. By introducing innovative technology to the juvenile industry, 4moms addresses the practical needs of parents with a range of childcare products. The company offers a variety of items, including baby gear and toys, aimed at fulfilling the diverse requirements of young children. With a team of over forty engineers, designers, and developers, 4moms has successfully placed its products in more than 500 stores across 24 countries, making a significant impact in the $8.9 billion U.S. juvenile products market.

4moms is a company based in Pittsburgh, Pennsylvania, that specializes in developing robotics technology-based products designed for children from prenatal stages to preschool age. By introducing innovative technology to the juvenile industry, 4moms addresses the practical needs of parents with a range of childcare products. The company offers a variety of items, including baby gear and toys, aimed at fulfilling the diverse requirements of young children. With a team of over forty engineers, designers, and developers, 4moms has successfully placed its products in more than 500 stores across 24 countries, making a significant impact in the $8.9 billion U.S. juvenile products market.

Dynamics Inc. designs and manufactures interactive payment cards that utilize programmable magnetic stripes to enhance electronic payment systems. Founded in 2007 and headquartered in Cheswick, Pennsylvania, the company offers a range of products, including multi-purpose security and loyalty cards for banks, as well as loyalty systems for merchants and health cards for consumers. Dynamics' technology allows for customizable features, providing enhanced choice, control, convenience, and security in transactions. The company has established strategic partnerships with SoftBank Corp. and its subsidiary. Dynamics operates as a subsidiary of Canadian Imperial Bank of Commerce, focusing on transforming payment methods through innovative card solutions.

Helomics Corporation, established in 1995 and headquartered in Pittsburgh, Pennsylvania, is a personalized healthcare company specializing in cancer care. It develops and delivers a portfolio of products to aid physicians and patients in making informed clinical decisions. Helomics' core technology, the Precision Cellular Analytical Platform, collects and analyzes cell cycle and proliferation data over an extended period. Key products include ChemoFx, BioSpeciFx, GeneFx Colon, and GeneFx Lung, which help physicians select effective treatments and understand potential drug responses or prognosis. The company also offers tumor profiling services, contract research and development, and biorepository and banking services. Helomics operates as a contract research organization (CRO), providing oncology insights for six primary cancers and using artificial intelligence and its D-CHIP platform to create personalized oncology roadmaps. It serves the pharmaceutical, diagnostic, biotechnology, and research industries, aiming to improve patient outcomes through personalized treatments and diagnostics.

Celerion, Inc. offers a range of clinical research and trial services to pharmaceutical and biotechnology companies, both in the United States and internationally. Founded in 2010 and based in Lincoln, Nebraska, with additional locations in Tempe, Arizona, and West Conshohocken, Pennsylvania, Celerion specializes in Applied Translational Medicine. This approach involves translating research findings into practical insights about drug action and effects in humans, which aids early drug development decisions. The company provides comprehensive services, including global clinical research, data management, biostatistics, medical writing, and bioanalytical services for both small and large molecules. With a clinical capacity of over 600 beds and a network of experienced scientific professionals, Celerion is recognized for its innovative strategies that facilitate early data generation, enabling clients to make informed go/no-go decisions in drug development.

Celerion, Inc. offers a range of clinical research and trial services to pharmaceutical and biotechnology companies, both in the United States and internationally. Founded in 2010 and based in Lincoln, Nebraska, with additional locations in Tempe, Arizona, and West Conshohocken, Pennsylvania, Celerion specializes in Applied Translational Medicine. This approach involves translating research findings into practical insights about drug action and effects in humans, which aids early drug development decisions. The company provides comprehensive services, including global clinical research, data management, biostatistics, medical writing, and bioanalytical services for both small and large molecules. With a clinical capacity of over 600 beds and a network of experienced scientific professionals, Celerion is recognized for its innovative strategies that facilitate early data generation, enabling clients to make informed go/no-go decisions in drug development.

Regulatory DataCorp, Inc. specializes in governance, risk, and compliance solutions aimed at Fortune 100 companies across various industries. Established in 2002 and headquartered in King of Prussia, Pennsylvania, with an office in Singapore, the company delivers precise risk alerts and ongoing monitoring to enhance protection and performance for its clients. Regulatory DataCorp’s offerings encompass a wide array of services, including anti-money laundering, know your customer, anti-bribery and corruption, and supplier due diligence. The company serves diverse sectors such as financial services, e-commerce, technology, energy, and manufacturing, helping these organizations achieve superior risk-screening outcomes and comply with financial regulations while minimizing customer effort.

Regulatory DataCorp, Inc. specializes in governance, risk, and compliance solutions aimed at Fortune 100 companies across various industries. Established in 2002 and headquartered in King of Prussia, Pennsylvania, with an office in Singapore, the company delivers precise risk alerts and ongoing monitoring to enhance protection and performance for its clients. Regulatory DataCorp’s offerings encompass a wide array of services, including anti-money laundering, know your customer, anti-bribery and corruption, and supplier due diligence. The company serves diverse sectors such as financial services, e-commerce, technology, energy, and manufacturing, helping these organizations achieve superior risk-screening outcomes and comply with financial regulations while minimizing customer effort.